Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
1 June 2015 |
Main ID: |
NCT02451605 |
Date of registration:
|
12/05/2015 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Regional Anesthesia for Knee Prothesis Surgery
|
Scientific title:
|
Regional Blockade for Knee Prothesis Surgery: Comparison Between Femoral, Sciatic and Adductor Canal Block |
Date of first enrolment:
|
June 2015 |
Target sample size:
|
40 |
Recruitment status: |
Not yet recruiting |
URL:
|
http://clinicaltrials.gov/show/NCT02451605 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Belgium
| | | | | | | |
Contacts
|
Name:
|
Pierre Goffin |
Address:
|
|
Telephone:
|
003243667180 |
Email:
|
goffin.pjc@gmail.com |
Affiliation:
|
|
|
Name:
|
Pierre Goffin |
Address:
|
|
Telephone:
|
003243667178 |
Email:
|
goffin.pjc@gmail.com |
Affiliation:
|
|
|
Name:
|
Jean-Francois Brichant |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
University Hospital of Liege |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- patients scheduled for total knee replacement surgery.
Exclusion Criteria:
- refusal to study,
- coagulation disorder,
- infection at the puncture site,
- preexisting neuropathy,
- allergy to local anesthetics,
- renal or hepatocellular insufficiency,
- context of chronic pain,
- drugs abuse,
- pregnant patient.
Age minimum:
18 Years
Age maximum:
75 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Total Knee Replacement
|
Intervention(s)
|
Procedure: Total knee replacement surgery.
|
Drug: Analgesic nerve blockade (Ropivacaine)
|
Primary Outcome(s)
|
Pain measurement with numeric pain scale : from 0 to 10 (maximal pain) in rest condition
[Time Frame: up to day 7]
|
Pain measurement with numeric pain scale (from 0 to 10) during active motorized mobilization (Kinetic)
[Time Frame: up to day 7]
|
Secondary Outcome(s)
|
Postintervention nausea vomiting
[Time Frame: at hour 0, at hours 6, at day 1]
|
Patient satisfaction
[Time Frame: at day 1]
|
Opioid consumption
[Time Frame: up to 48 hours]
|
Secondary ID(s)
|
2014-000677-39
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|